Europe Market for Liquid Embolics 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Europe Market for Liquid Embolics 2017 - MedCore" report to their offering.

Embolization is a non-surgical, minimally invasive procedure that involves the selective occlusion of blood vessels by purposely introducing emboli. The procedure is a minimally invasive alternative to open surgery and is performed by interventional radiologists and interventional neuroradiologists. Liquid embolic products are used for the embolization of both aneurysms (weakened balloon-like portions of a vessel) and arterio-venous malformations (AVMs).

Growth in unit sales will be very stable over the forecast period. A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) compared interventional and conservative treatment of arteriovenous malformations in the brain and found that conservative management with medication was more effective than embolization. However, some experts have expressed concerns regarding the clinical conclusions of the study due to relatively short follow-up and difficulties with patient recruitment. Therefore even due the market limiter imposed by the trial results, unit sales have continues to grow steadily in line with procedural growth. Approximately two to three units of liquid embolics are needed on average for procedures.

The ASP is also expected to remain stable as there is only one competitor in the market. There may be others that enter the market over the forecast period but this technology has held a monopoly on this market for many years now.

Key Topics Covered:

1. Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.2 Disease Pathology And Disorders

2.2.1 Introduction

2.2.2 General Diagnostics And Neurosurgery

2.2.3 Tumor And Brain Cancer

2.2.4 Brain Arteriovenous Malformations

2.2.5 Ischemic Stroke

2.2.6 Brain Aneurysm

2.2.7 Disorders Related To Cerebrospinal Fluids And Intracranial Pressure

2.2.7.1 Hydrocephalus And Intracranial Pressure Disorder

2.2.7.2 Cerebral Edema

2.2.8 Indication For Neuromodulation

2.2.9 Traumatic Brain Injury

3. Country Profiles

3.1 Introduction

3.1.1 Population

3.1.2 GDP Per Capita

3.1.3 Price Index

4. Product Assessment

4.1 Product Portfolios

4.1.1 Liquid Embolics

4.1.1.1 Introduction

4.1.1.2 Product Matrix For Liquid Embolics Market: Core Companies

4.2 Regulatory Issues And Recalls

4.2.1 Liquid Embolics

4.3 Clinical Trials

4.3.1 Liquid Embolic

5. Liquid Embolic Market

5.1 Introduction

5.2 Market Analysis And Forecast

5.3 Drivers And Limiters

5.4 Competitive Market Share Analysis

For more information about this report visit http://www.researchandmarkets.com/research/q7hffc/europe_market_for

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices